Home/Filings/4/0001209191-22-033526
4//SEC Filing

Hillan Kenneth J. 4

Accession 0001209191-22-033526

CIK 0001804591other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:26 PM ET

Size

5.1 KB

Accession

0001209191-22-033526

Insider Transaction Report

Form 4
Period: 2022-06-01
Hillan Kenneth
Head of Therapeutics
Transactions
  • Tax Payment

    Class A Common Stock

    2022-06-01$2.82/sh4,627$13,048209,464 total
Footnotes (1)
  • [F1]The closing price on June 1, 2022, the transaction date.

Issuer

23andMe Holding Co.

CIK 0001804591

Entity typeother

Related Parties

1
  • filerCIK 0001600359

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:26 PM ET
Size
5.1 KB